Merck & Co., Inc. Capital Expenditures 2021-2026 | MRK
Beta
What is capital expenditures?
Capital expenditures (CapEx) can be defined as money spent on acquiring, maintaining, or upgrading physical assets such as property, buildings, and equipment.
What is Merck & Co., Inc.'s current capital expenditures?
Merck & Co., Inc. (MRK) annual capital expenditures for 2025 was $4.11B, a 21.95% increase from 2024. Merck & Co., Inc. capital expenditures for the quarter ending March 31, 2026 was $991.0M.
What was Merck & Co., Inc.'s capital expenditures in 2024?
Merck & Co., Inc. annual capital expenditures for 2024 was $3.37B, a 12.71% decline from 2023.
What was Merck & Co., Inc.'s capital expenditures in 2023?
Merck & Co., Inc. annual capital expenditures for 2023 was $3.86B, a 11.96% decline from 2022.
What is Merck & Co., Inc.'s 4-year capital expenditures CAGR?
Merck & Co., Inc. capital expenditures grew at a compound annual growth rate (CAGR) of 1.94% from FY2021 to FY2025, going from $4.45B to $4.11B over 4 years.
Capital Expenditures History
Year-over-year comparison from 10-K annual reports
Key Statistics
Trend Direction
Stable
CAGR-1.9%
FY2021
$4.45B
→
FY2025
$4.11B
2122232425
4 years selected
Company: Merck & Co., Inc.Ticker: MRKSector: HealthcareIndustry: Pharmaceutical PreparationsView company profile →